Download presentation
Presentation is loading. Please wait.
Published byMilo Potter Modified over 8 years ago
1
DR.S. MANSORI INFECTIOUS DISEASE SPECIALIST QAZVIN UNIVERCITY OF MEDICAL SCIENCE
2
The initial manifestation of HIV infection in one half to two thirds of recently infected individuals a mononucleosis-like illness
3
first described in 1985 by Cooper and colleagues an acute mononucleosis-like syndrome in 11 of 12 homosexual men who seroconverted for HIV anti-bodies.
4
The incidence of the acute retroviral syndrome is not precisely known. It was reported in 40% to 90% in one study In one study of 378 persons with acute retroviral syndrome, injection drug users had or reported symptoms less frequently than persons who acquired HIV through sexual transmission.
5
The clinical features of the acute retroviral syndrome are nonspecific and variable The onset of the illness ranges from 1 to 6 weeks aftAer exposure to the virus but peaks at 3 weeks
6
Fever, sweats, malaise, myalgias, anorexia, nausea, diarrhea, and a nonexudative pharyngitis are prominent symptoms.
7
Bilateral facial nerve palsy Appendicitis
8
Two thirds of patients may have a truncal exanthem that may be maculopapular, roseola-like, or urticarial. Findings of skin biopsies are nonspecific, with perivascular lymphocytic infiltrates and dermal mononuclear cell infiltrates
10
In addition to aseptic meningitis, neurologic symptoms occur in a minority of patients and may include encephalitis, peripheral neuropathy, and an acute ascending polyneuropathy (Guillain-Barré syndrome)
11
In patients with neurologic symptoms, the cerebrospinal fluid may show a lymphocytic pleocytosis with normal levels of protein and glucose.
12
cervical, occipital, or axillary lymphadenopathy rash, and, less commonly, hepatosplenomegaly. Oral aphthous ulcerations Oral and esophageal candidiasis during the seroconversion illness has been reported. Symptoms generally resolve in 10 to 15 days.
13
P.jirovecii pneumonia, cryptococcal meningitis, and Candida esophagitis have been reported in several cases. Their occurrence is probably caused by the depression of the CD4+ cell count that generally accompanies acute HIV infection.
14
reduced total lymphocyte count elevated sedimentation rate negative heterophil antibody test elevated aminotransferase and alkaline phosphatase levels.
15
Initially, the total lymphocyte count, including both CD4+ and CD8+ T lymphocytes decreases, with a normal ratio of CD4+ to CD8+ cells. Within several weeks, both the CD4+ and CD8+ cell populations begin to increase. The rise in CD8+ cell numbers is relatively greater than that in CD4+
16
The ratio of CD4+ to CD8+ cells usually remains inverted as the acute illness resolves, primarily because of excess numbers of CD8+ cells.
17
antibody reactivity on enzyme immunoassay testing is not found until 14 to 21 days. plasma HIV RNA, becomes positive at about 5 days after infection HIV p24 antigen may be detected after 10 days,
18
HIV p24 antigen may be detected in the serum and cerebro-spinal fluid in about 75% of patients with primary HIV infection within 2 weeks of exposure, often coincidentally with the onset of symptoms.
19
The most sensitive marker for acute HIV infection, however, is plasma HIV RNA, which is markedly elevated in most patients. false-positive HIV RNA tests may occur, but high-level viremia is diagnostic of acute infection in the absence of anti-HIV antibodies
20
infectious mononucleosis influenza, viral hepatitis, measles rubella primary herpes simplex virus (HSV) infection, cytomegalovirus secondary syphilis.
21
careful history to elicit risks for HIV infection laboratory tests
22
lower the viral setpoint, lead to enhanced CD4+ and CD8+ HIV specific responses, and decrease the severity of acute disease. BUT may not provide any long-term benefit. potential toxicity of long-term therapy the risk for developing drug resistance
23
ART is recommended for persons with early HIV infection—the acute phase of infection up to 6 months after infection.
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.